Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii

E Dahdouh1, S H Shoucair1, S E Salem1

  • 1Clinical Microbiology Laboratory, Faculty of Medicine & Medical Science, University of Balamand, P.O. Box 100, Tripoli, Lebanon.

Thescientificworldjournal
|January 23, 2015
PubMed

Insights

The mutant prevention concentration (MPC) of carbapenems is useful against resistant Pseudomonas and Acinetobacter. MPC values correlate with resistance levels, not specific resistance mechanisms, guiding optimal antibiotic therapy.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Carbapenem resistance in Pseudomonas spp. and Acinetobacter spp. poses a significant clinical challenge.
  • Understanding resistance mechanisms is crucial for effective antimicrobial stewardship.

Purpose of the Study:

  • To evaluate the utility of the mutant prevention concentration (MPC) of carbapenems against clinical isolates of Pseudomonas and Acinetobacter.
  • To investigate the relationship between MPC and carbapenem resistance mechanisms.

Main Methods:

  • Antibiotic Susceptibility Testing, Double Disk Synergy, and various phenotypic tests were used to detect resistance mechanisms.
  • Minimum Inhibitory Concentration (MIC) and MPC were determined via broth macrodilution and plate dilution.
  • Tested 10 clinical isolates of Pseudomonas spp. and Acinetobacter baumannii.

Main Results:

  • Four Acinetobacter baumannii strains produced MBL, two Oxacillinase, and one ESBL. Two Pseudomonas spp. isolates produced both KPC and MBL.
  • Resistant strains exhibited higher MPC values compared to susceptible strains.
  • Mutant Selection Window (MSW) depended on the degree of resistance, not specific mechanisms.

Conclusions:

  • The usefulness of MPC is value-dependent and recommended for individual isolate assessment before treatment.
  • Therapeutic strategies should consider T>MSW (time above mutant selection window) over T>MIC (time above minimum inhibitory concentration).

Related Concept Videos

Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
132
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
61
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
125
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.1K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
158